NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $557,000 | -4.6% | 6,348 | -4.9% | 0.10% | -2.9% |
| Q4 2021 | $584,000 | +6.0% | 6,674 | -1.0% | 0.10% | -1.0% |
| Q3 2021 | $551,000 | -12.3% | 6,740 | -2.0% | 0.10% | -18.0% |
| Q2 2021 | $628,000 | +4.1% | 6,881 | -2.5% | 0.13% | -8.6% |
| Q1 2021 | $603,000 | -10.1% | 7,060 | +0.9% | 0.14% | -13.0% |
| Q4 2020 | $671,000 | +10.4% | 6,999 | +0.1% | 0.16% | -4.7% |
| Q3 2020 | $608,000 | -1.1% | 6,994 | -0.6% | 0.17% | -13.3% |
| Q2 2020 | $615,000 | +3.4% | 7,036 | -2.5% | 0.20% | -17.4% |
| Q1 2020 | $595,000 | -14.6% | 7,216 | -1.9% | 0.24% | +0.4% |
| Q4 2019 | $697,000 | +7.7% | 7,358 | 0.0% | 0.24% | +4.4% |
| Q3 2019 | $647,000 | -1.7% | 7,358 | +4.4% | 0.22% | -28.6% |
| Q2 2019 | $658,000 | -8.5% | 7,047 | -5.7% | 0.32% | -10.8% |
| Q1 2019 | $719,000 | +10.8% | 7,474 | -1.2% | 0.35% | -11.5% |
| Q4 2018 | $649,000 | – | 7,562 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |